Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

524

HTML

2897

Figures (1-4)

123

Tables (1-5)

151

Sum=3695

May 14, 2010 (publication date) through Apr 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. May 14, 2010; 16(18): 2227-2234
Published online May 14, 2010. doi: 10.3748/wjg.v16.i18.2227

Full Size Figure Download Figure

Figure 2 The cost-effectiveness acceptability curve for MARS vs standard medical therapy in the historical control group in acute liver failure.

Citation: Kantola T, Mäklin S, Koivusalo AM, Räsänen P, Rissanen A, Roine R, Sintonen H, Höckerstedt K, Isoniemi H. Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure. World J Gastroenterol 2010; 16(18): 2227-2234
URL: https://www.wjgnet.com/1007-9327/full/v16/i18/2227.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i18.2227